InvestorsHub Logo
Followers 80
Posts 5250
Boards Moderated 0
Alias Born 11/18/2013

Re: None

Monday, 10/23/2023 10:29:57 AM

Monday, October 23, 2023 10:29:57 AM

Post# of 209
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Aravive (ARAV - Research Report) today and set a price target of $7.00. The company's shares opened today at $1.40.According to TipRanks, Pantginis is an analyst with an average return of -19.7% and a 26.95% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Actinium Pharmaceuticals, Decibel Therapeutics, and Biomea Fusion.Aravive has an analyst consensus of Strong Buy, with a price target consensus of $9.67, which is a 590.71% upside from current levels. In a report released on October 27, Roth Capital also maintained a Buy rating on the stock with a $10.00 price target.
https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-aravive-arav-2?utm_source=advfn.com&utm_medium=
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARAV News